Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jason Drew Smith

General Counsel at UroGen Pharma Ltd. (URGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $212K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 9SEC URGNUroGen Pharma Ltd. Sell 1,51953,141 held (−3%) $42.54 $65K -18.8%
Feb 11SEC URGNUroGen Pharma Ltd. Sell 2,65452,934 held (−5%) $19.69 $52K +75.5%
Feb 11SEC URGNUroGen Pharma Ltd. Sell 1,60851,326 held (−3%) $19.69 $32K +75.5%
Feb 11SEC URGNUroGen Pharma Ltd. Sell 3,21755,588 held (−5%) $19.69 $63K +75.5%